Research graph
References from Astaxanthin is associated with improved cerebral perfusion and exploratory hippocampal phospholipid alterations in chronic cerebral hypoperfusion. Local targets link to admitted publications; unresolved targets remain external evidence.
Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent
10.3390/md19040201 · 2021 · External reference
Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment
10.1002/alz.13408 · 2024 · External reference
Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species
10.3389/fcell.2022.866156 · 2022 · External reference
Phospholipidomics in clinical trials for brain disorders: Advancing our understanding and therapeutic potentials
10.1007/s12035-023-03793-y · 2024 · External reference
A brief overview of a mouse model of cerebral hypoperfusion by bilateral carotid artery stenosis
10.1177/0271678x231154597 · 2023 · External reference
A circRNA ceRNA network involved in cognitive dysfunction after chronic cerebral hypoperfusion
10.18632/aging.205387 · 2024 · External reference
Bilateral common carotid artery stenosis in mice: A model of chronic cerebral hypoperfusion-induced vascular cognitive impairment
2024 · External reference
Recommendations for good practice in MS-based lipidomics
10.1016/j.jlr.2021.100138 · 2021 · External reference
The lipidomics reporting checklist: A framework for transparency of lipidomic experiments and repurposing resource data
10.1016/j.jlr.2024.100621 · 2024 · External reference
Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats
2022 · External reference
2-(4-Methylthiazol-5-yl) ethyl nitrate hydrochloride ameliorates cognitive impairment via modulation of oxidative stress and nuclear factor kappa B signaling pathway in chronic cerebral hypoperfusion-associated spontaneously hypertensive rats
10.3390/antiox13050585 · 2024 · External reference
Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
10.1016/j.phrs.2022.106482 · 2022 · External reference
Adiponectin ameliorates hypoperfusive cognitive deficits by boosting a neuroprotective microglial response
10.1016/j.pneurobio.2021.102125 · 2021 · External reference
Adenosine A2A receptor in bone marrow-derived cells mediated macrophages M2 polarization via PPARγ-P65 pathway in chronic hypoperfusion situation
10.3389/fnagi.2021.792733 · 2022 · External reference
Lipid flipping in the omega-3 fatty-acid transporter
10.1038/s41467-023-37702-7 · 2023 · External reference
Lipidome atlas of the adult human brain
10.1038/s41467-024-48734-y · 2024 · External reference
Chronic cerebral hypoperfusion: A critical feature in unravelling the etiology of vascular cognitive impairment
10.1186/s40478-023-01590-1 · 2023 · External reference
LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from ferroptosis
10.1021/acschembio.2c00317 · 2022 · External reference
Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats
10.1016/j.bcp.2022.114980 · 2022 · External reference
Plasmalogen in the brain: Effects on cognitive functions and behaviors attributable to its properties
10.1016/j.brainresbull.2022.08.008 · 2022 · External reference
PCYT1A deficiency disturbs fatty acid metabolism and induces ferroptosis in the mouse retina
2024 · External reference
Astaxanthin rescues memory impairments in rats with vascular dementia by protecting against neuronal death in the hippocampus
10.1007/s12017-024-08796-z · 2024 · External reference
Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A
10.1038/s41586-021-03782-y · 2021 · External reference
Brain lipidomics: From functional landscape to clinical significance
10.1126/sciadv.adc9317 · 2022 · External reference
The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3
10.1038/s41467-021-27244-1 · 2021 · External reference
Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment
10.1002/alz.13408 · ExternalCitation · doi-reference
Astaxanthin rescues memory impairments in rats with vascular dementia by protecting against neuronal death in the hippocampus
10.1007/s12017-024-08796-z · ExternalCitation · doi-reference
Phospholipidomics in clinical trials for brain disorders: Advancing our understanding and therapeutic potentials
10.1007/s12035-023-03793-y · ExternalCitation · doi-reference
Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats
10.1016/j.bcp.2022.114980 · ExternalCitation · doi-reference
Plasmalogen in the brain: Effects on cognitive functions and behaviors attributable to its properties
10.1016/j.brainresbull.2022.08.008 · ExternalCitation · doi-reference
Recommendations for good practice in MS-based lipidomics
10.1016/j.jlr.2021.100138 · ExternalCitation · doi-reference
The lipidomics reporting checklist: A framework for transparency of lipidomic experiments and repurposing resource data
10.1016/j.jlr.2024.100621 · ExternalCitation · doi-reference
Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
10.1016/j.phrs.2022.106482 · ExternalCitation · doi-reference
Adiponectin ameliorates hypoperfusive cognitive deficits by boosting a neuroprotective microglial response
10.1016/j.pneurobio.2021.102125 · ExternalCitation · doi-reference
LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from ferroptosis
10.1021/acschembio.2c00317 · ExternalCitation · doi-reference
The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3
10.1038/s41467-021-27244-1 · ExternalCitation · doi-reference
Lipid flipping in the omega-3 fatty-acid transporter
10.1038/s41467-023-37702-7 · ExternalCitation · doi-reference
Lipidome atlas of the adult human brain
10.1038/s41467-024-48734-y · ExternalCitation · doi-reference
Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A
10.1038/s41586-021-03782-y · ExternalCitation · doi-reference
Brain lipidomics: From functional landscape to clinical significance
10.1126/sciadv.adc9317 · ExternalCitation · doi-reference
A brief overview of a mouse model of cerebral hypoperfusion by bilateral carotid artery stenosis
10.1177/0271678x231154597 · ExternalCitation · doi-reference
Chronic cerebral hypoperfusion: A critical feature in unravelling the etiology of vascular cognitive impairment
10.1186/s40478-023-01590-1 · ExternalCitation · doi-reference
A circRNA ceRNA network involved in cognitive dysfunction after chronic cerebral hypoperfusion
10.18632/aging.205387 · ExternalCitation · doi-reference
Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species
10.3389/fcell.2022.866156 · ExternalCitation · doi-reference
Adenosine A2A receptor in bone marrow-derived cells mediated macrophages M2 polarization via PPARγ-P65 pathway in chronic hypoperfusion situation
10.3389/fnagi.2021.792733 · ExternalCitation · doi-reference
2-(4-Methylthiazol-5-yl) ethyl nitrate hydrochloride ameliorates cognitive impairment via modulation of oxidative stress and nuclear factor kappa B signaling pathway in chronic cerebral hypoperfusion-associated spontaneously hypertensive rats
10.3390/antiox13050585 · ExternalCitation · doi-reference
Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent
10.3390/md19040201 · ExternalCitation · doi-reference
